We are live on ! Find out more
NTUS

Natus Medical Inc

Delisted

NTUS was delisted on the 20th of July, 2022.

169 hedge funds and large institutions have $794M invested in Natus Medical Inc in 2021 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 67 increasing their positions, 55 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

22% more repeat investments, than reductions

Existing positions increased: 67 | Existing positions reduced: 55

0% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 18

1% less funds holding

Funds holding: 170169 (-1)

3% less capital invested

Capital invested by funds: $818M → $794M (-$23.9M)

Holders
169
Holders Change
-1
Holders Change %
-0.59%
% of All Funds
2.96%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
18
Increased
67
Reduced
55
Closed
18
Calls
$47K
Puts
Net Calls
+$47K
Net Calls Change
-$1.05M
Name Holding Trade Value Shares
Change
Change in
Stake
BlackRock
1
BlackRock
New York
$161M -$2.1M -82,582 -1%
Vanguard Group
2
Vanguard Group
Pennsylvania
$74.3M +$225K +8,829 +0.3%
Victory Capital Management
3
Victory Capital Management
Texas
$57.9M +$1.56M +61,068 +3%
Wells Fargo
4
Wells Fargo
California
$45.3M +$2.91M +114,025 +7%
State Street
5
State Street
Massachusetts
$33.3M -$1.03M -40,609 -3%
Dimensional Fund Advisors
6
Dimensional Fund Advisors
Texas
$32.7M +$51.4K +2,016 +0.2%
Janus Henderson Group
7
Janus Henderson Group
United Kingdom
$28.7M +$86.2K +3,384 +0.3%
N
8
Nuveen
North Carolina
$22.3M -$279K -10,933 -1%
Ameriprise
9
Ameriprise
Minnesota
$21.5M +$1.85M +72,647 +9%
Goldman Sachs
10
Goldman Sachs
New York
$17M +$118K +4,630 +0.7%
Impax Asset Management Group
11
Impax Asset Management Group
United Kingdom
$16.5M +$2.55M +100,000 +18%
Wellington Management Group
12
Wellington Management Group
Massachusetts
$16M -$872K -34,243 -5%
Geode Capital Management
13
Geode Capital Management
Massachusetts
$14.8M +$68.6K +2,693 +0.5%
JP Morgan Chase
14
JP Morgan Chase
New York
$14.1M -$1.46M -57,290 -9%
Renaissance Technologies
15
Renaissance Technologies
New York
$12.3M -$833K -32,700 -6%
Northern Trust
16
Northern Trust
Illinois
$11.7M -$330K -12,951 -3%
Arrowstreet Capital
17
Arrowstreet Capital
Massachusetts
$11.6M -$40.8K -1,600 -0.3%
TCM
18
Tributary Capital Management
Nebraska
$11.1M +$892K +35,006 +9%
Fisher Asset Management
19
Fisher Asset Management
Washington
$10.3M -$700K -27,455 -6%
Charles Schwab
20
Charles Schwab
California
$9.72M +$1.88M +73,884 +24%
Diamond Hill Capital Management
21
Diamond Hill Capital Management
Ohio
$8.82M
Bank of New York Mellon
22
Bank of New York Mellon
New York
$8.05M +$160K +6,281 +2%
Norges Bank
23
Norges Bank
Norway
$6.96M -$880K -34,552 -11%
Principal Financial Group
24
Principal Financial Group
Iowa
$6.71M -$109K -4,280 -2%
Invesco
25
Invesco
Georgia
$5.47M -$370K -14,509 -6%

NTUS Hedge Fund Activity: Q3 2021 in Review

169 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Natus Medical Inc (NTUS) for Q3 2021, worth a combined $794M — down 2.9% from $818M a quarter earlier.

Fund positioning in NTUS was balanced in Q3 2021: 18 funds opened new positions, 18 closed out, 67 added to existing stakes and 55 trimmed.

The largest buyer was Wells Fargo, adding an estimated $2.91M. The largest seller was Fenimore Asset Management, exiting entirely with an estimated $2.61M sold.

  • 169 institutional investors held Natus Medical Inc (NTUS) as of Q3 2021, down from 170 in Q2 2021.
  • Funds reported $794M of Natus Medical Inc stock for Q3 2021, down 2.9% quarter-over-quarter.
  • 18 funds opened new Natus Medical Inc positions in Q3 2021 and 18 closed out, a net change of 0 holders.
  • The largest Natus Medical Inc buyer in Q3 2021 was Wells Fargo, an estimated $2.91M added.
  • The largest Natus Medical Inc seller in Q3 2021 was Fenimore Asset Management, an estimated $2.61M sold.

Based on aggregated 13F filings for Q3 2021.